Brian Stover, MD

This phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in children, and FHWT is the most common subtype.…

Investigator

Brian Stover

Status

Accepting Candidates

Ages

N/A - 30 Years

Sexes

All

This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with an alkylating agents. Alkylating agents are part of standard…

Investigator

Brian Stover

Status

Accepting Candidates

Ages

N/A - 39 Years

Sexes

Female

This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that is growing, spreading, or getting worse (progressive), has come back (relapsed) after…

Investigator

Brian Stover

Status

Accepting Candidates

Ages

180 Days - 22 Years

Sexes

All